(Total Views: 341)
Posted On: 09/14/2020 8:35:49 AM
Post# of 81

$ATRA News Article - Atara Biotherapeutics To Present Clinical Data in Epstein-Barr Virus-Driven (EBV+) Acquired & Primary Immunodeficiency Lymphoproliferative Diseases (AID-LPD and PID-LPD) from Tab-Cel Expanded Access Program in e-Poster at ESMO 2020 Virtual Congress https://marketwirenews.com/news-releases/atar...28978.html


My Twitter: WhyteStocks